Increased NO production in lysinuric protein intolerance

L. Mannucci, F. Emma, M. Markert, C. Bachmann, O. Boulat, R. Carrozzo, G. Rizzoni, C. Dionisi-Vici

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune symptoms and usually increased plasma citrulline. In order to better understand the underlying mechanism, we studied the plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in three LPI patients and the in vitro NO2- production in cultured fibroblasts. Our data show that NO2- levels are increased in the plasma of patients with LPI. Similarly, NO2- release in the medium of cultured fibroblasts was increased. On this basis, we hypothesize that some of the poorly understood clinical signs of LPI could be related to the activation of the NO-citrulline pathway.

Original languageEnglish
Pages (from-to)123-129
Number of pages7
JournalJournal of Inherited Metabolic Disease
Volume28
Issue number2
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Citrulline
Diamino Amino Acids
Fibroblasts
Pulmonary Alveolar Proteinosis
Nitrites
Nitrates
Renal Insufficiency
Mutation
Lysinuric Protein Intolerance
Genes
In Vitro Techniques

ASJC Scopus subject areas

  • Endocrinology
  • Genetics
  • Genetics(clinical)

Cite this

Increased NO production in lysinuric protein intolerance. / Mannucci, L.; Emma, F.; Markert, M.; Bachmann, C.; Boulat, O.; Carrozzo, R.; Rizzoni, G.; Dionisi-Vici, C.

In: Journal of Inherited Metabolic Disease, Vol. 28, No. 2, 01.2005, p. 123-129.

Research output: Contribution to journalArticle

Mannucci, L. ; Emma, F. ; Markert, M. ; Bachmann, C. ; Boulat, O. ; Carrozzo, R. ; Rizzoni, G. ; Dionisi-Vici, C. / Increased NO production in lysinuric protein intolerance. In: Journal of Inherited Metabolic Disease. 2005 ; Vol. 28, No. 2. pp. 123-129.
@article{56c18e0097a64e98bae20184cefadceb,
title = "Increased NO production in lysinuric protein intolerance",
abstract = "Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune symptoms and usually increased plasma citrulline. In order to better understand the underlying mechanism, we studied the plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in three LPI patients and the in vitro NO2- production in cultured fibroblasts. Our data show that NO2- levels are increased in the plasma of patients with LPI. Similarly, NO2- release in the medium of cultured fibroblasts was increased. On this basis, we hypothesize that some of the poorly understood clinical signs of LPI could be related to the activation of the NO-citrulline pathway.",
author = "L. Mannucci and F. Emma and M. Markert and C. Bachmann and O. Boulat and R. Carrozzo and G. Rizzoni and C. Dionisi-Vici",
year = "2005",
month = "1",
doi = "10.1007/s10545-005-5954-x",
language = "English",
volume = "28",
pages = "123--129",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Increased NO production in lysinuric protein intolerance

AU - Mannucci, L.

AU - Emma, F.

AU - Markert, M.

AU - Bachmann, C.

AU - Boulat, O.

AU - Carrozzo, R.

AU - Rizzoni, G.

AU - Dionisi-Vici, C.

PY - 2005/1

Y1 - 2005/1

N2 - Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune symptoms and usually increased plasma citrulline. In order to better understand the underlying mechanism, we studied the plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in three LPI patients and the in vitro NO2- production in cultured fibroblasts. Our data show that NO2- levels are increased in the plasma of patients with LPI. Similarly, NO2- release in the medium of cultured fibroblasts was increased. On this basis, we hypothesize that some of the poorly understood clinical signs of LPI could be related to the activation of the NO-citrulline pathway.

AB - Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune symptoms and usually increased plasma citrulline. In order to better understand the underlying mechanism, we studied the plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in three LPI patients and the in vitro NO2- production in cultured fibroblasts. Our data show that NO2- levels are increased in the plasma of patients with LPI. Similarly, NO2- release in the medium of cultured fibroblasts was increased. On this basis, we hypothesize that some of the poorly understood clinical signs of LPI could be related to the activation of the NO-citrulline pathway.

UR - http://www.scopus.com/inward/record.url?scp=19444377182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19444377182&partnerID=8YFLogxK

U2 - 10.1007/s10545-005-5954-x

DO - 10.1007/s10545-005-5954-x

M3 - Article

C2 - 15877200

AN - SCOPUS:19444377182

VL - 28

SP - 123

EP - 129

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 2

ER -